InsidersTradesSigma
Follow the Medytox Solutions, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 26 January 2016 (Disposition). Among the most active insiders: Aella, Ltd.. All data is free.
Analysts rate Medytox Solutions, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Medytox Solutions, Inc. is a company listed on the XNAS market, specializing in the development of innovative solutions in the healthcare sector. It focuses on the research and commercialization of biological and pharmaceutical products.